483
Synexa Life SciencesSynexa Life Sciences – FDA 483
Record Details
An FDA inspection of Synexa Life Sciences (Pty) Ltd. in Cape Town, South Africa, revealed significant deficiencies in method validation and data integrity practices. The firm was cited for improper data exclusion, inadequate stability assessments, inconsistent application of acceptance criteria, and incomplete documentation across various assays. These issues indicate a lack of robust quality control in their contract research operations.
- Company
- Synexa Life Sciences
- Product type
- drugs
View Company Profile
ID · 098da068-63a4-4a29-b179-10a5c13d3960
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.